Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tata

Showing results (201-210 of 272) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 19, 2007
Synthesis of novel HIV protease inhibitors (PI) with activity against PI-resistant virusSubharekha Raghavan, Zhijian Lu, Teresa Beeson, et al.
American Journal of Respiratory and Critical Care Medicine|July 12, 2017
Delayed Alveolar Epithelialization: A Distinct Pathology in Diffuse Acute Lung InjuryMartin S Taylor, Raghu R Chivukula, Laura C Myers, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Combinatorial library of indinavir analogues: replacement for the aminoindanol at P2'Subharekha Raghavan, Zheng Yang, Ralph T Mosley, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
The design, synthesis and evaluation of novel HIV-1 protease inhibitors with high potency against PI-resistant viral strainsFengqi Zhang, Kevin T Chapman, William A Schleif, et al.
Journal of Medicinal Chemistry|October 16, 1992
Highly potent, orally active diester macrocyclic human renin inhibitorsA E Weber, M G Steiner, P A Krieter, et al.
Journal of Clinical Lipidology|February 5, 2011
Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humansEseng Lai, M Gerard Waters, James R Tata, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virusZhijian Lu, Joann Bohn, Tom Rano, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2010
The discovery of high affinity agonists of GPR109a with reduced serum shift and improved ADME propertiesJason E Imbriglio, Daniel DiRocco, Rena Bodner, et al.
The American Journal of Pathology|February 25, 2018
A Conserved Distal Lung Regenerative Pathway in Acute Lung InjuryMartin S Taylor, Raghu R Chivukula, Laura C Myers, et al.
Journal of Pharmacological and Toxicological Methods|July 24, 2007
Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonistsEster Carballo-Jane, Lynn S Gerckens, Silvi Luell, et al.
Pageof 28

Showing results (201-210 of 272) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry Letters|August 19, 2007
Synthesis of novel HIV protease inhibitors (PI) with activity against PI-resistant virusSubharekha Raghavan, Zhijian Lu, Teresa Beeson, et al.
American Journal of Respiratory and Critical Care Medicine|July 12, 2017
Delayed Alveolar Epithelialization: A Distinct Pathology in Diffuse Acute Lung InjuryMartin S Taylor, Raghu R Chivukula, Laura C Myers, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Combinatorial library of indinavir analogues: replacement for the aminoindanol at P2'Subharekha Raghavan, Zheng Yang, Ralph T Mosley, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
The design, synthesis and evaluation of novel HIV-1 protease inhibitors with high potency against PI-resistant viral strainsFengqi Zhang, Kevin T Chapman, William A Schleif, et al.
Journal of Medicinal Chemistry|October 16, 1992
Highly potent, orally active diester macrocyclic human renin inhibitorsA E Weber, M G Steiner, P A Krieter, et al.
Journal of Clinical Lipidology|February 5, 2011
Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humansEseng Lai, M Gerard Waters, James R Tata, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virusZhijian Lu, Joann Bohn, Tom Rano, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2010
The discovery of high affinity agonists of GPR109a with reduced serum shift and improved ADME propertiesJason E Imbriglio, Daniel DiRocco, Rena Bodner, et al.
The American Journal of Pathology|February 25, 2018
A Conserved Distal Lung Regenerative Pathway in Acute Lung InjuryMartin S Taylor, Raghu R Chivukula, Laura C Myers, et al.
Journal of Pharmacological and Toxicological Methods|July 24, 2007
Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonistsEster Carballo-Jane, Lynn S Gerckens, Silvi Luell, et al.
Pageof 28